This statistic presents the forecast of Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA) of Pfizer Inc in 2021 and 2022. The EBITDA of Pfizer was expected to amount to approximately 26.8 billion U.S. dollars in 2021.
Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pfizer
Global positioning
7
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic World's most valuable pharmaceutical brands 2023 by brand value
- Basic Statistic Top pharma companies worldwide by number of originated drugs 2024
- Premium Statistic Largest M&A pharmaceutical deals ever as of 2024
- Basic Statistic Sales forecast of top pharmaceutical companies worldwide 2028
- Basic Statistic Top global biopharma drugs by lifetime sales up to 2028
Key company data
6
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Pfizer's net income 2006-2023
- Basic Statistic Earnings per Pfizer share 2008-2023
- Premium Statistic Pfizer's expenditure on research and development 2006-2023
- Basic Statistic Pfizer's total assets 2006-2023
- Premium Statistic Pfizer's total number of employees 2006-2023
Business distribution
4
Competitors
5
COVID-19
6
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Premium Statistic Pfizer/BioNTech COVID-19 vaccines delivered by country income group 2021
- Basic Statistic COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Comparison of select COVID-19 vaccines 2022, by efficacy
- Basic Statistic Comparison of select COVID-19 vaccines worldwide 2022, by efficacy against Delta
Further related statistics
10
- Value of global financial assets 1990-2013
- Structure of investment portfolio of Allianz Group 2014-2023
- Rio Tinto's net income 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Value of assets managed by global ETFs 2010-2017, by region
- Number of mutual funds worldwide 2011-2014, by country
- Senior chief financial officer salary per annum in Switzerland 2023
- BayWa's revenue by segment 2010-2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Syngenta's sales in the crop protection segment worldwide 2013-2022
Further Content: You might find this interesting as well
Statistics
- Value of global financial assets 1990-2013
- Structure of investment portfolio of Allianz Group 2014-2023
- Rio Tinto's net income 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Value of assets managed by global ETFs 2010-2017, by region
- Number of mutual funds worldwide 2011-2014, by country
- Senior chief financial officer salary per annum in Switzerland 2023
- BayWa's revenue by segment 2010-2022
- Return on average common shareholder equity at Goldman Sachs 2009-2023
- Syngenta's sales in the crop protection segment worldwide 2013-2022
Quandl. (October 19, 2021). Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved June 10, 2024, from https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/
Quandl. "Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars)." Chart. October 19, 2021. Statista. Accessed June 10, 2024. https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/
Quandl. (2021). Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: June 10, 2024. https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/
Quandl. "Forecast of Ebitda of Pfizer Inc in 2021 and 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 19 Oct 2021, https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/
Quandl, Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/ (last visited June 10, 2024)
Forecast of EBITDA of Pfizer Inc in 2021 and 2022 (in million U.S. dollars) [Graph], Quandl, October 19, 2021. [Online]. Available: https://www.statista.com/statistics/633499/forecast-of-ebitda-of-pfizer/